Home › Research › Biomarkers
Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease
Noguchi M, Sato T, Nagai K, Utagawa I, Suzuki I, Arito M, Iizuka N, Suematsu N et al.. International journal of geriatric psychiatry, 2013-11-05
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To find a blood biomarker and disease-related peptides in Alzheimer's disease (AD), we comprehensively detected serum peptides. Methods Ion intensity of serum peptides from 62 AD patients and 82 control subjects was measured by mass spectrometry. Results A total of 157 peptides were detected from 30 AD patients and 30 healthy control (HC) subjects. Sixty out of the 157 peptide profiles discriminated between the AD and HC groups. Sixteen out of the 60 peptides were identified, 10 out of which were fragments of a fibrinogen α chain (FIBA). Among the 10 peptides, four and six peptides were derived from fibrinopeptide A (FPA, Aα1-16) and the C-terminal region of the αC-domain (αCDC, Aα557-610), respectively. The profile of 10 FIBA-derived peptides combined with age discriminated between the two groups with an area under the receiver operating characteristic curve (AUROC) of 0.940. Validation of this model using a testing set of 32 AD patients and 19 HC subjects showed an AUROC of 0.717, sensitivity of 65.6%, and specificity of 73.7% by a cutoff value of 0.56420. Another value, 0.04029, showed sensitivity of 96.9%, suggesting that subjects with values less than 0.04029 rarely possess AD. FPA and αCDC showed increased ion intensity in the AD group compared with the HC group (p < 0.05). Conclusions The profile of 10 FIBA-derived peptides combined with age would be a candidate biomarker for AD, which facilitates screening of the disease. The significant release of FPA and αCDC may be involved in the aberrant coagulation that leads to vascular damage in AD.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Noguchi, M., Sato, T., Nagai, K., Utagawa, I., Suzuki, I., Arito, M., et al. (2014). Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease. International journal of geriatric psychiatry. https://doi.org/10.1002/gps.4047
Vancouver
Noguchi M, Sato T, Nagai K, Utagawa I, Suzuki I, Arito M, et al. Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease. International journal of geriatric psychiatry. 2014. doi:10.1002/gps.4047. PMID: 24190360.
BibTeX
@article{noguchi2014-24190360,
author = {Noguchi, M. and Sato, T. and Nagai, K. and Utagawa, I. and Suzuki, I. and Arito, M. and Iizuka, N. and Suematsu, N. and others},
title = {{Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease}},
journal = {International journal of geriatric psychiatry},
year = {2014},
doi = {10.1002/gps.4047},
pmid = {24190360},
url = {https://doi.org/10.1002/gps.4047}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results A total of 157 peptides were detected from 30 AD patients and 30 healthy control (HC) subjects.
- Another value, 0.04029, showed sensitivity of 96.9%, suggesting that subjects with values less than 0.04029 rarely possess AD.
- FPA and αCDC showed increased ion intensity in the AD group compared with the HC group (p < 0.05).
- The significant release of FPA and αCDC may be involved in the aberrant coagulation that leads to vascular damage in AD.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants157
- Effect size65.6%; 73.7%; 96.9%
- Evidence strengthLow
How this study scored 48/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 28 of the 58 points we could judge it on, which is 48 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (International journal of geriatric psychiatry) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2014 — within 20 year(s) of the newest study here |
| Sample size | 2 / 4 | 157 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 24190360) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 28 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 28 of the 58 points we could judge it on is 48 out of 100. |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.